These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 1933399)

  • 41. Morphine withdrawal syndrome: differential participation of structures located within the amygdaloid complex and striatum of the rat.
    Calvino B; Lagowska J; Ben-Ari Y
    Brain Res; 1979 Nov; 177(1):19-34. PubMed ID: 574050
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The effects of different 4-aminopyridine and morphine combinations on the intensity of morphine abstinence.
    Koyuncuoğlu H; Nurten A; Enginar N; Ozerman B; Kara I
    Pharmacol Res; 2001 Mar; 43(3):245-50. PubMed ID: 11401416
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Mianserin and trazodone significantly attenuate the intensity of opioid withdrawal symptoms in mice.
    Schreiber S; Backler MM; Herman I; Shamir D; Rigai T; Bar-Hamburger R; Pick CG
    Addict Biol; 2003 Mar; 8(1):107-14. PubMed ID: 12749364
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Destruction of the locus coeruleus decreases physical signs of opiate withdrawal.
    Maldonado R; Koob GF
    Brain Res; 1993 Mar; 605(1):128-38. PubMed ID: 8467382
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Pregabalin role in inhibition of morphine analgesic tolerance and physical dependency in rats.
    Hasanein P; Shakeri S
    Eur J Pharmacol; 2014 Nov; 742():113-7. PubMed ID: 25220244
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Trazodone and m-chlorophenylpiperazine. Concentration in brain and receptor activity in regions in the brain associated with anxiety.
    Smith TM; Suckow RF
    Neuropharmacology; 1985 Nov; 24(11):1067-71. PubMed ID: 4080105
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Evidence that 5-hydroxytryptamine in the forebrain is involved in naloxone-precipitated jumping in morphine-dependent rats.
    Cervo L; Romandini S; Samanin R
    Br J Pharmacol; 1983 Aug; 79(4):993-6. PubMed ID: 6686075
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [The effect of ritanserin on the formation and expression of an opiate abstinence syndrome].
    Verbitskaia EV; Kudriashova MF
    Eksp Klin Farmakol; 1997; 60(1):19-21. PubMed ID: 9162274
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Opioid and cannabinoid modulation of precipitated withdrawal in delta(9)-tetrahydrocannabinol and morphine-dependent mice.
    Lichtman AH; Sheikh SM; Loh HH; Martin BR
    J Pharmacol Exp Ther; 2001 Sep; 298(3):1007-14. PubMed ID: 11504797
    [TBL] [Abstract][Full Text] [Related]  

  • 50. beta-Lactam antibiotic inhibits development of morphine physical dependence in rats.
    Rawls SM; Baron DA; Kim J
    Behav Pharmacol; 2010 Mar; 21(2):161-4. PubMed ID: 20215965
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effects of taurine on tolerance to and dependence on morphine in mice.
    Contreras E; Tamayo L
    Arch Int Pharmacodyn Ther; 1984 Feb; 267(2):224-31. PubMed ID: 6538778
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Withdrawal and bidirectional cross-withdrawal responses in rats treated with adenosine agonists and morphine.
    Coupar IM; Tran BL
    Life Sci; 2001 Jul; 69(7):779-90. PubMed ID: 11487090
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A preliminary study of the effects of nighttime administration of the serotonin agonist, m-CPP, on sleep architecture and behavior in healthy volunteers.
    Lawlor BA; Newhouse PA; Balkin TJ; Molchan SE; Mellow AM; Murphy DL; Sunderland T
    Biol Psychiatry; 1991 Feb; 29(3):281-6. PubMed ID: 2015332
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Prenatal exposure to morphine or naloxone intensifies morphine dependence at maturity.
    Koyuncuoğlu H; Aricioğlu F
    Pharmacol Biochem Behav; 1993 Apr; 44(4):939-41. PubMed ID: 8469703
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effects of intracavernosal trazodone hydrochloride: animal and human studies.
    Azadzoi KM; Payton T; Krane RJ; Goldstein I
    J Urol; 1990 Nov; 144(5):1277-82. PubMed ID: 1977931
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Phelorphan, an inhibitor of enzymes involved in the biodegradation of enkephalins, affected the withdrawal symptoms in chronic morphine-dependent rats.
    Haffmans J; Walsum MV; van Amsterdam JC; Dzoljic MR
    Neuroscience; 1987 Jul; 22(1):233-6. PubMed ID: 2888045
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Mechanisms of the development of trazodone withdrawal symptoms.
    Otani K; Tanaka O; Kaneko S; Ishida M; Yasui N; Fukushima Y
    Int Clin Psychopharmacol; 1994; 9(2):131-3. PubMed ID: 8056996
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effect of adenosine analogues on the expression of opiate withdrawal in rats.
    Dionyssopoulos T; Hope W; Coupar IM
    Pharmacol Biochem Behav; 1992 Jun; 42(2):201-6. PubMed ID: 1631178
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Comparison of selective and complete inhibitors of enkephalin-degrading enzymes on morphine withdrawal syndrome.
    Maldonado R; Daugé V; Callebert J; Villette JM; Fournié-Zaluski MC; Feger J; Roques BP
    Eur J Pharmacol; 1989 Jun; 165(2-3):199-207. PubMed ID: 2776828
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effects of harman and harmine on naloxone-precipitated withdrawal syndrome in morphine-dependent rats.
    Aricioglu-Kartal F; Kayir H; Tayfun Uzbay I
    Life Sci; 2003 Sep; 73(18):2363-71. PubMed ID: 12941438
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.